Skip to content
Search

Latest Stories

Pharmacists included in visa extension scheme

Pharmacists are included in the government's latest decision to extend the visas of overseas healthcare workers during the coronavirus crisis.

Pharmacists, midwives and radiographers and social workers with visas due to expire before October 1 will receive a free automatic one-year extension, the Home Secretary announced on Wednesday (29).


The scheme will apply to those working both in the NHS and independent sector and benefit “approximately 3,000 vital health and care workers and their families.”

The latest decision follows an announcement by Patel in late March that overseas doctors, nurses and paramedics would be given a free one-year visa extension.

Making the announcement, Patel said: “We are incredibly grateful to all overseas health and care workers fighting this invisible enemy.

“We have already announced the extension of visas for NHS doctors, nurses and paramedics. Now we are going further by extending this offer to hundreds of other frontline health and care workers, both in the NHS and in the independent sector.

“These extensions will be automatic, free and include exemption from the Immigration Health Surcharge.

The Home Secretary also said families of any foreign healthcare worker who dies due to contracting the virus would be granted immediate indefinite leave to remain in the UK without having to pay a fee.

The extension comes into effect immediately and overseas healthcare workers who have paid for an unresolved application will be offered the option of a refund.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less